Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
Crossref DOI link: https://doi.org/10.1007/s40744-017-0060-8
Published Online: 2017-03-28
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fleischmann, Roy
van Vollenhoven, Ronald F.
Vencovský, Jiri
Alten, Rieke
Davies, Owen
Mountian, Irina
de Longueville, Marc
Carter, David
Choy, Ernest
Funding for this research was provided by:
UCB Pharma.